Tecan Group Ltd (TCHBF PINK) stock market data APIs
$211.9802
-10.75(-5.1%)
as of July 4, 2025
Try our APIs with
free plan!
Tecan Group Ltd Financial Data Overview
Price chart is built with
Anychart
Tecan Group AG provides laboratory instruments and solutions in biopharmaceuticals, forensics, and clinical diagnostics in Europe, North America, Asia, and internationally. It operates in two segments, Life Sciences Business and Partnering Business. The company offers liquid handling and automation, microplate readers and washers, software, consumables, NGS reagents, immunoassays and antibodies, and Tecan Labwerx, an end-to-end automation solution. It also provides PARAMIT, a contract design and manufacturing service; Synergence, a customized OEM system; Cavro, a standard and customized OEM component; and onsite and depot repairs, as well as remote services and digital solutions. The company was founded in 1980 and is headquartered in Männedorf, Switzerland.
Prev. Close
211.9802
Open
201.2344
High
211.9802
Low
201.2344
52 wk Range
182.45-331.3233
Market Cap
2 718 M
P/E Ratio
31.6264
Shares Outstanding
12 826 K
Revenue
934 M
EPS
3.7016
Dividends (Yield)
0.0172
Beta
0.962
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Tecan Group Ltd data using free add-ons & libraries
Get Tecan Group Ltd Fundamental Data
Tecan Group Ltd Fundamental data includes:
- Net Revenue: 934 M
- EBITDA: 109 M
- Earnings Per Share: 6
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2021-06-30
- EPS/Forecast: 0
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Tecan Group Ltd News
New
Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms outlook for full year 2025
Tecan Group AG Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Q1 2025 Qualitative Update: Tecan reports performance in line with expectations and confirms ou...
BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours
Combines BioSkyrb’s new ResolveOME™ Whole Genome and Transcriptome Single-Cell Core Kit 384-well assay with Uno Single Cell Dispenser™ provided by Tecan in a single workflow Enables scalable, hi...
Tecan reports key outcomes from Annual General Meeting 2025
Tecan Group AG Tecan reports key outcomes from Annual General Meeting 2025 Stable dividend of CHF 3.00 per share Lukas Braunschweiler, Myra Eskes, Oliver Fetzer, Matthias Gillner, Christa Kreuzburg,...
Tecan Expands Portfolio for Specialty Diagnostics With an Asset Purchase Relating to Certain ELISA Kits
MÄNNEDORF, Switzerland, April 03, 2025--(BUSINESS WIRE)--Tecan Group (SIX Swiss Exchange: TECN) today announced an agreement to acquire certain assets relating to key ELISA immunoassay products from ...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
